CPT1C and colorectal carcinoma: The expression levels of CCL22 (Figure 13(a)), CD36 (Figure 13(b)), CPA3 (Figure 13(c)), CPT1C (Figure 13(d)), KCNE4 (Figure 13(e)), NFATC1 (Figure 13(f)), RASGRP2 (Figure 13(g)), and SLC2A3 (Figure 13(h)) between the high risk score and low risk score were validated based on the 566 CRC samples.